Table 4. Number of cases of overall IPD (N) and serotyped IPD (nST), the proportion of serotyped IPD among overall IPD, the proportion of non-PCV10-IPD (nnon-PCV10) among nST, the IR of overall IPD and serotyped IPD/106 pm, the serotype-specific IPD ranked from R1-R10 by IR/106 pm and alphanumerically in the pre-period (2009–2011), early post-period (2013–2014) and late post-period (2015–2016) among the <5 and ≥50 years old, Austria.
Overall IPD |
Serotyped IPD |
Portion of non-PCV10 IPD |
Serotype-specific IPD | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R1 | R2 | R3 | R4 | R5 | R6 | R7 | R8 | R9 | R10 | |||||||
Age | Study period | N | IR /106 pm | nST | IR /106 | nnon-PCV10/nST in % | IR / 106 pm | |||||||||
<5 | Pre | 14 | 3 | 19A | 18C | 1 | 7F | 11A | 19F | 6A | 6B | |||||
108 | 7.63 | 77 | 5.44 | 46.8 | 1.06 | 0.64 | 0.42 | 0.35 | 0.28 | 0.28 | 0.21 | 0.21 | 0.21 | 0.21 | ||
Early post | 14 | 19A | 1 | 10A | 15A | 19F | 24F | 3 | 6A | 7F | ||||||
45 | 4.66 | 32 | 3.31 | 53.1 | 0.62 | 0.31 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | ||
Late post | 19A | 3 | 14 | 15B | 23A | 23F | 7F | 1 | 10A | 19F | ||||||
50 | 4.95 | 36 | 3.56 | 72.2 | 0.79 | 0.49 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.10 | 0.10 | 0.10 | ||
≥50 | Pre | 3 | 14 | 7F | 19A | 19F | 4 | 6A | 22F | 9N | 9V | |||||
677 | 6.14 | 638 | 5.79 | 63.2 | 1.08 | 0.48 | 0.42 | 0.34 | 0.27 | 0.26 | 0.26 | 0.24 | 0.21 | 0.18 | ||
Early post | 3 | 19A | 7F | 14 | 4 | 6C | 9N | 22F | 11A | 23B | ||||||
530 | 6.70 | 472 | 5.97 | 76.5 | 1.4 | 0.39 | 0.32 | 0.27 | 0.24 | 0.24 | 0.24 | 0.22 | 0.18 | 0.18 | ||
Late post | 3 | 19A | 22F | 8 | 14 | 9N | 23B | 6C | 4 | 11A | ||||||
679 | 8.24 | 608 | 7.38 | 83.2 | 2.12 | 0.55 | 0.45 | 0.32 | 0.29 | 0.25 | 0.22 | 0.22 | 0.19 | 0.18 |